 |
|
methotrexate
An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | alpha-methopterin
amethopterin
Methotrexatum
methylaminopterin
Metotrexato | | | | US brand names: | | Abitrexate
Folex
Folex PFS
Methotrexate LPF
Mexate
Mexate-AQ | | | | Foreign brand names: | | Brimexate
Emtexate
Emthexat
Emthexate
Farmitrexat
Fauldexato
Lantarel
Ledertrexate
Lumexon
Maxtrex
Medsatrexate
Metex
Methoblastin
Metrotex
Novatrex
Texate
Tremetex
Trexeron
Trixilem | | | | Abbreviation: | | MTX | | | | Code names: | | CL-14377
WR-19039 | | | | Chemical structure names: | | - 4-amino-10-methylfolic acid
- 4-amino-4-deoxy-10-methylpteroyl-L-glutamic acid
- N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
| | |
| Previous: | methanol extraction residue of BCG, methazolamide, Methazolastone, methionine C 11, Methosarb | | Next: | Methotrexate LPF, methotrexate-e therapeutic implant, methoxsalen, methoxy polyethylene glycol epoetin beta, methoxyamine |
|
|
